NEUARTIGE HETERODIMERE PROTEINE

Patent europeic · EP3620473 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3620473
Numer da la dumonda
EP19187150
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
14-01-2014
Publitgà
11-03-2020
Concedì
27-05-2026
La protecziun finescha il pli tard
13-01-2034
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
C07K 16/46 (2006.01)
Prioritad
US 201361752348 P 14.01.2013
US 201361764954 P 14.02.2013
US 201361778157 P 12.03.2013
US 201361780334 P 13.03.2013
US 201361818153 P 01.05.2013
US 201361818410 P 01.05.2013
US 201361913832 P 09.12.2013
US 201361913870 P 09.12.2013
Derivà da
EP14738267
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 26-06-2026

    Represchentant inscrit

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 26.06.2026

  2. 27-05-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 27.05.2026

Partidas

Possessur

Xencor, Inc.

465 North Halstead Street Suite 200, Pasadena, CA 91107, US

Represchentant

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventur

DESJARLAIS, John

Monrovia, CA 91016, US

MOORE, Gregory

Monrovia, CA 91016, US

RASHID, Rumana

Monrovia, CA 91016, US

BERNETT, Matthew J.

Monrovia, CA 91016, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.